Matches in Nanopublications for { ?s ?p "[Using this technique we have studied the expression levels of several oncogenes including MYC, SIS, FMS, p53, FOS and RAF in both normal hematopoietic cells and bone marrow (BM) cells obtained from acute myelogenous leukemia (AML) patients at presentation, at relapse and in complete remission (CR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- assertion description "[Using this technique we have studied the expression levels of several oncogenes including MYC, SIS, FMS, p53, FOS and RAF in both normal hematopoietic cells and bone marrow (BM) cells obtained from acute myelogenous leukemia (AML) patients at presentation, at relapse and in complete remission (CR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Using this technique we have studied the expression levels of several oncogenes including MYC, SIS, FMS, p53, FOS and RAF in both normal hematopoietic cells and bone marrow (BM) cells obtained from acute myelogenous leukemia (AML) patients at presentation, at relapse and in complete remission (CR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP479083.RAMlSK8RNBy2vXFclKLU7SOxmM-YOQIWf_zh9bgRCzT94130_assertion description "[Using this technique we have studied the expression levels of several oncogenes including MYC, SIS, FMS, p53, FOS and RAF in both normal hematopoietic cells and bone marrow (BM) cells obtained from acute myelogenous leukemia (AML) patients at presentation, at relapse and in complete remission (CR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP479083.RAMlSK8RNBy2vXFclKLU7SOxmM-YOQIWf_zh9bgRCzT94130_provenance.
- assertion description "[Using this technique we have studied the expression levels of several oncogenes including MYC, SIS, FMS, p53, FOS and RAF in both normal hematopoietic cells and bone marrow (BM) cells obtained from acute myelogenous leukemia (AML) patients at presentation, at relapse and in complete remission (CR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Using this technique we have studied the expression levels of several oncogenes including MYC, SIS, FMS, p53, FOS and RAF in both normal hematopoietic cells and bone marrow (BM) cells obtained from acute myelogenous leukemia (AML) patients at presentation, at relapse and in complete remission (CR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1295405.RAe7emF1dg5bNfYbh4gEPkZ4Z5_EFz6nNcMADSzuK26Ag130_assertion description "[Using this technique we have studied the expression levels of several oncogenes including MYC, SIS, FMS, p53, FOS and RAF in both normal hematopoietic cells and bone marrow (BM) cells obtained from acute myelogenous leukemia (AML) patients at presentation, at relapse and in complete remission (CR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295405.RAe7emF1dg5bNfYbh4gEPkZ4Z5_EFz6nNcMADSzuK26Ag130_provenance.
- NP865219.RAlGQWQjM1fmeLGpOSj_hIMNeu1X48jWBFvIbJJx5OA0k130_assertion description "[Using this technique we have studied the expression levels of several oncogenes including MYC, SIS, FMS, p53, FOS and RAF in both normal hematopoietic cells and bone marrow (BM) cells obtained from acute myelogenous leukemia (AML) patients at presentation, at relapse and in complete remission (CR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865219.RAlGQWQjM1fmeLGpOSj_hIMNeu1X48jWBFvIbJJx5OA0k130_provenance.
- NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_assertion description "[Using this technique we have studied the expression levels of several oncogenes including MYC, SIS, FMS, p53, FOS and RAF in both normal hematopoietic cells and bone marrow (BM) cells obtained from acute myelogenous leukemia (AML) patients at presentation, at relapse and in complete remission (CR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295404.RAD1sxE6NaHcK5cOAwgKJ_-5meLi0s3AWK3NXNxDbMXck130_provenance.
- NP410668.RAsEI0rgne_gHXrUmzBsdPBYr6bg4O7i-7JsdkFs8yRJ8130_assertion description "[Using this technique we have studied the expression levels of several oncogenes including MYC, SIS, FMS, p53, FOS and RAF in both normal hematopoietic cells and bone marrow (BM) cells obtained from acute myelogenous leukemia (AML) patients at presentation, at relapse and in complete remission (CR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410668.RAsEI0rgne_gHXrUmzBsdPBYr6bg4O7i-7JsdkFs8yRJ8130_provenance.
- NP664369.RAEzLHNDvZARdsszK1Avnsaqoptz_vbnGbUvN2yI8e7Yw130_assertion description "[Using this technique we have studied the expression levels of several oncogenes including MYC, SIS, FMS, p53, FOS and RAF in both normal hematopoietic cells and bone marrow (BM) cells obtained from acute myelogenous leukemia (AML) patients at presentation, at relapse and in complete remission (CR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664369.RAEzLHNDvZARdsszK1Avnsaqoptz_vbnGbUvN2yI8e7Yw130_provenance.
- NP1295406.RA1IRbdzFJ4pKqACzln77LdgMnga5AdPLxeD4281icQDo130_assertion description "[Using this technique we have studied the expression levels of several oncogenes including MYC, SIS, FMS, p53, FOS and RAF in both normal hematopoietic cells and bone marrow (BM) cells obtained from acute myelogenous leukemia (AML) patients at presentation, at relapse and in complete remission (CR).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295406.RA1IRbdzFJ4pKqACzln77LdgMnga5AdPLxeD4281icQDo130_provenance.